Tailored biologics aim to improve psoriasis and joint health
NCT ID NCT07149792
First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 24 times
Summary
This study compares two ways of choosing biologic drugs for people with psoriasis or psoriatic arthritis: one uses a pre-screen strategy, the other follows standard guidelines. About 50 adults aged 18-75 are participating across multiple hospitals in Taiwan. Researchers will track skin and joint symptoms, quality of life, and artery thickness over up to 3 years to see which approach works better.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Taichung Vertenans General Hospital
RECRUITINGTaichung, Taiwan, 886, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Taichung Veterans Hospital
NOT_YET_RECRUITINGTaichung, Taiwan, 407219, Taiwan
Conditions
Explore the condition pages connected to this study.